Background-Assessment of the vasodepressor reflex in carotid sinus syndrome is influenced by the method of execution of the carotid sinus massage and the coexistence of the cardioinhibitory reflex. Methods and Results-Carotid sinus massage reproduced spontaneous symptoms in 164 patients in the presence of hypotension or bradycardia (method of symptoms). When an asystolic pause was induced, the vasodepressor reflex was reassessed after suppression of the asystolic reflex by means of 0.02 mg/kg IV atropine. An isolated vasodepressor form was found in 32 (20%) patients, who had lowest systolic blood pressure (SBP) of 65±15 mm Hg. Of these, only 21 (66%) patients had an SBP fall ≥50 mm Hg, which is the universally accepted cut-off value for the diagnosis of the vasodepressor form. Conversely, a lowest SBP value of ≤85 mm Hg (corresponding to the fifth percentile) detected 97% of vasodepressor patients, but was also present in 84% of the 132 patients with an asystolic reflex. These latter patients had both asystole ≥3 s (mean 7.6±2.2 s) and SBP fall to 63±22 mm Hg: in 46 (28%) patients, symptoms persisted after atropine (mixed form), in the remaining 86 (52%) patients, symptoms did not (cardioinhibitory form) persist. Conclusions-The current definition of ≥50 mm Hg SBP fall failed to identify one third of patients with isolated vasodepressor form. A cut-off value of symptomatic SBP of ≤85 mm Hg seems more appropriate, but it is unable to identify cardioinhibitory forms. In asystolic forms, atropine testing is able to distinguish a cardioinhibitory form from a mixed form. (Circ Arrhythm Electrophysiol. 2014;7:505-510.)
T he classical criteria for the diagnosis and classification of carotid sinus syndrome (CSS), that is, ≥3 s asystolic pause (cardioinhibitory type), a fall in systolic blood pressure (SBP) ≥50 mm Hg (vasodepressor type), or both [mixed type]), are based on previous studies, most of which were small and subject to the technical limitations of their time. 1 Now that standard practice involves continuous blood pressure (BP) measurement and the execution of carotid sinus massage (CSM) in the standing position, a vasodepressor component can be identified more precisely and is found in most patients with an asystolic pause. 2, 3 A positive response induced by CSM does not necessarily equate with clinical relevance. 1, 4 Indeed, a ≥3 s asystole or a fall in SBP ≥50 can frequently be observed in the general older population. 4 Consequently, the current definition of CSS requires the reproduction of syncope, ie, the so-called Method of Symptoms, in addition to the documentation of abnormal cardioinhibitory or vasodepressor forms. 5, 6 Clinical Perspective on p 510
The aim of this study was to assess the magnitude of the vasodepressor reflex in patients affected by CSS, as diagnosed by the Method of Symptoms. The Method of Symptoms does not require any cut-off value of the asystolic pause or of the SBP fall induced by CSM, as positivity of the test is based on the reproduction of symptoms.
Methods
In accordance with the 2004 and 2009 guidelines of the European Society of Cardiology, 5, 6 CSM was performed on all patients aged ≥40 years with syncope whose diagnosis had remained uncertain after initial evaluation consisting of history, physical examination, standard ECG, systemic BP measurement in the supine and upright positions and, if appropriate, echocardiogram and ECG monitoring. The only patients excluded were those with a permanent pacemaker. The criteria for patient selection have been previously described. 7 CSM was performed during continuous electrocardiographic and noninvasive BP monitoring (Task Force Monitor, CNSystem) and consisted of manual compression with the tips of the second, third, and fourth fingers of one hand at the site of the maximum carotid pulse, between the angle of the jaw and the cricoid cartilage on the anterior margin of the sternocleidomastoid muscle, with the face rotated contralaterally. The massage was applied up and down the carotid artery on the right and then on the left side and in the supine and then in the upright positions for 10 s, to allow symptoms to develop; the time interval between massages had to be long enough to allow heart rate and BP values to return to the baseline. Thus, each patient underwent 4 massages; the sequence was completed even in the event of positivity of 1 massage. Even if an asystolic pause is evoked by CSM, the possibility still exists that the patient may also exhibit a marked vasodepressor response. To assess the contribution of the vasodepressor component (which may otherwise be hidden), CSM was repeated after intravenous administration of 0.02 mg/kg of atropine. Atropine eliminates vagally induced asystolic pauses, thereby unmasking the vasodepressor phenomenon. 8, 9 SBP was recorded, in 5-mm Hg intervals, as the average of the systolic values recorded for 5 s; this time the average has been shown to yield the best correlation between orthostatic hypotension and falls. 10 In accordance with the Method of Symptoms, carotid sinus hypersensitivity (CSH) was diagnosed when CSM elicited abnormal cardioinhibition (ie, asystole ≥3 s) or vasodepression (ie, fall in SBP >50 mm Hg); CSS was established when spontaneous symptoms (syncope or presyncope) were reproduced in the presence of CSH. 2, 3, 8, 9, 11 Owing to its low specificity, CSH alone was not considered diagnostic 1, 3, 4 because it can frequently be observed in the general older population, 4 and only symptomatic CSH was considered diagnostic. An isolated vasodepressor form was defined when CSM reproduced symptoms with a fall in SBP during at least 1 massage in the absence of asystole ≥3 s. In patients who had baseline asystole ≥3 s, a mixed form was diagnosed when symptoms persisted after the elimination of asystole by means of atropine, and a cardioinhibitory form was diagnosed when symptoms disappeared after atropine 8, 9, 11 (see Figures I and II in the Data Supplement). In each patient, the massage that reproduced the spontaneous symptoms was considered for analysis. In the event of 2 or more symptomatic massages, the one with the lowest SBP value (for vasodepressor forms) or with the longest asystolic pause (for cardioinhibitory and mixed forms) was considered for analysis. This study and the protocol were approved by the institutional review committee, and the subjects gave informed consent.
Statistical Analysis
The lowest value of SPB obtained during the index CSM was considered for quantification of the magnitude of the vasodepressor reflex with the Method of Symptoms (see Methods). Continuous data are shown as average ± SD. Absolute and relative frequencies were used to report categorical data. The unpaired Student's t test was used to compare continuous variables. Fisher exact test or Chi square test was used for comparison between proportions, as appropriate. Analysis of the SBP trajectories between groups was performed by fitting a generalized estimating equations model for repeated data based on a normal distribution using an exchangeable correlation structure. The model had the SBP as dependent variables, and baseline values, time, and group as explanatory variables. Analyses were performed by SAS 9.3.
Results
From July 2005 to July 2012, 1855 patients were studied. CSH was found in 454 patients (25%). CSS was found in 164 (8.8%) patients: 132 (80%) patients had an asystolic reflex (mean pause 7.6±2.2 s) and 32 (20%) patients had an isolated vasodepressor reflex (mean lowest SBP 65±15 mm Hg; Figure 1 ). Their clinical characteristics are shown in Table 1 . Compared with the patients who had asystole, the patients with isolated vasodepressor had a shorter history of syncope, more frequently associated presyncopal episodes and orthostatic hypotension and less structural heart disease. CSM caused syncope in 108 patients and presyncope in 56 patients (Table 2) . Compared with presyncope, the patients who had syncope had a longer asystole, a greater fall in SBP and reached a lowest minimum SBP value; the type of response was less frequently vasodepressor. The maximum response in the vasodepressor form was always obtained during standing CSM, 59% of times on the right side and 41% of times on the left side. Only 21 (66%) patients had an SBP fall ≥50 mm Hg, which is the universally accepted cutoff value for the diagnosis of the vasodepressor form. Conversely, a lowest SBP value of ≤85 mm Hg (which is the fifth percentile of the present population) was able to detect 97% of vasodepressor patients. Patients with an asystolic form had a similar BP fall to a minimum value of 63±22 mm Hg; a SBP fall ≥50 mm Hg was present in 74% and a lowest SBP value of ≤85 mm Hg was present in 84% of these patients. However, SBP rose more quickly toward baseline values than in the vasodepressor form ( Figure 2 ; Tables I and II in the Data Supplement). The maximum response was obtained during supine CSM in 28% and during upright CSM in 72% of cases, and on the right side in 71% and on the left side in 29% of cases.
In the patients with an asystolic form, the magnitude of the vasodepressor reflex was reassessed after intravenous atropine injection: in 46 patients, symptoms persisted after atropine (mixed form), whereas in the remaining 86 patients, symptoms did not (cardioinhibitory form; Figure 1 ) persist. The SBP pattern in the patients with a mixed form was similar in magnitude and duration to that observed in vasodepressor patients, but it was different from that seen in the patients with the cardioinhibitory form, who had higher SBP values before and during the massage and a smaller SBP drop (Figures 2 and 3) . No patient had asystole after atropine administration, and heart rate increased by a similar magnitude in both groups. Interestingly, SBP values showed only mild differences between cardioinhibitory and mixed forms during baseline CSM, thus making these 2 forms difficult to distinguish without atropine testing; the length of the maximum asystolic pause was also similar (Table 3 and Figure 3 ).
Discussion
This study shows that when reproduction of symptoms is required for the diagnosis of CSS, the current definition of ≥50 mm Hg SBP fall failed to identify one third of patients with isolated vasodepressor form (34% false-negative rate). A cut-off value of lowest SBP of ≤85 mm Hg seems more appropriate to correlate vasodepressor with symptoms in these elderly patients, in whom baseline BP was low-to-normal (most were taking multiple hypotensive drugs). Moreover, this value is consistent with the findings of physiology studies, which have shown that the SBP at heart level at which symptoms because of hypoperfusion occur is 80 mm Hg while standing. 1, 3 Nevertheless, an SBP fall below 85 mm Hg also occurs in most patients with an asystolic pause, and virtually, all patients have an associated vasodepressor reflex. A pure cardioinhibitory form does not exist.
Atropine testing was able to distinguish a dominant cardioinhibitory form from a mixed form, which are largely indistinguishable if CSM is performed without atropine. We found that one third of the patients with an asystolic pause had a similar symptomatic SBP pattern to those with isolated vasodepressor when vagally induced cardioinhibition was eliminated by atropine. Thus, these patients had both marked cardioinhibitory and vasodepressor reflexes, which justify the classification of mixed form. Conversely, the other two thirds of patients with an asystolic pause had an asymptomatic SBP fall of lower magnitude and shorter duration. Thus, in these patients, the dominant reflex was cardioinhibitory. In the literature, there is no consensus on how best to unmask the vasodepressor response. In accordance with Thomas et al 9 and with the concept of the method of symptoms, we adopted the persistence of symptoms after atropine administration. However, some authors have defined vasodepressor as a fall in SBP ≥30 or ≥50 mm Hg induced by CSM after intravenous atropine administration. 12, 13 To confuse matters further, others have diagnosed a mixed form without eliminating the cardioinhibitory reflex. 4, [14] [15] [16] [17] The length of asystolic pause, which causes symptoms in cardioinhibitory and mixed forms, is generally much longer than the historical 3-s cut-off value adopted in both cardioinhibitory and mixed forms, but no real cut-off value exists (see the Data Supplement). Moreover, no cut-off value in the length of the asystolic reflex is able to distinguish cardioinhibitory from mixed forms.
During baseline CSM (without atropine), the vagal and sympathetic mechanisms induced by the massage have different temporal patterns of onset. Asystolic pause is under vagal control and occurs almost immediately. The immediate SBP fall observed during asystole is explained by the reduction in arterial capacity because of the prolonged absence of flow during ventricular asystole; its duration is the time needed to refill the vascular bed once a rhythm resumes, and SBP usually requires a few beats to recover. 2, 3 The withdrawal of sympathetic activity is nearly synchronous with the fall in heart rate, but the nadir of the total peripheral resistance (ie, the sympathetically mediated effector organ response) is, however, only reached after ≈10 s, owing to the relatively slow neural activation of vascular smooth muscle contraction. 3, 18 The initial SBP fall is because of the sum of these 2 mechanisms (vagally induced asystole plus sympathetic withdrawal). SBP takes ≈30 s to return to the baseline in asystolic forms and >45 s in isolated vasodepressor forms (Figure 2 ). The cause of the delayed recovery is the vasodepressor component of the reflex. 2 Depression of cardiac contractility during recovery after standstill because of the combination of vagal stimulation and sympathetic inhibition may play an additional role. 3 The muscarinic anticholinergic effect of atropine eliminates asystole and the hemodynamic-related BP fall, but has no influence on the sympathetic withdrawal induced by CSM. Atropine has been used in CSM since the pioneering studies on CSS, 9, 19, 20 though many physicians do not currently use it in their clinical practice and research. In this study, after atropine administration, the SBP curve of the patients with a mixed form was fairly similar to that observed in the isolated vasodepressor form (Figure 3) . Thus, our interpretation is that sympathetic withdrawal was the component most responsible for the SBP fall and symptoms. Conversely, in the cardioinhibitory form, once the hemodynamic effect caused by the asystolic pause had been eliminated, sympathetic withdrawal caused only a mild late fall in SBP to values that were compatible with preserved cerebral flow, and symptoms did not occur. During off-drug CSM, SBP returned to baseline values within 30 s, whereas on atropine, the SBP curve failed to reach baseline values for >45 s. Therefore, atropine seems to overestimate the vasodepressor reflex of the CCS. Because atropine has no direct hypotensive effect in the supine position, the reason for this is uncertain. However, in addition to its muscarinic effect, atropine has complex effects, which are posture dependent. Indeed, previous studies 21, 22 showed that atropine exerted a hypotensive effect on standing, with a fall in SBP of 10 to 40 mm Hg in healthy adults. Moreover, in patients with vasovagal syncope, Weissler et al 23, 24 observed that atropine increased cardiac output and BP in the supine position but not in the upright posture. These findings were attributed to a ganglionic block (nicotinic effect) of sufficient magnitude to prevent adequate vasoconstriction, resulting in vascular pooling in the legs and the splanchnic area. The same mechanism could be responsible for the slow recovery of BP following upright CSM after atropine that was observed in this study. However, as the decrease in upright SBP following atropine before CSM was modest, being on average 5 mm Hg in cardioinhibitory forms and 9 mm Hg in mixed forms (Table 3) , it is unlikely that it altered the clinical interpretation of the test.
We infer that a mechanism similar to that which we observed during CSM also occurs during spontaneous episodes. This quantification of the vasodepressor component is clinically relevant because it has been shown that pacemaker therapy is less effective when the vasodepressor effect is large, compared with that of predominant cardioinhibitory. 11, 17, 25, 26 In an previous study, we found that syncope or presyncope recurred in 12% of patients affected by the dominant cardioinhibitory form and in 58% of those affected by the mixed form. 26 Lopes et al 17 showed that mixed CSS was the only independent predictor of symptom recurrence. Moreover, in the absence of a marked vasodepressor effect, most patients with prolonged asystole will benefit from simple, easy-to-implant, and less costly ventricular pacing. 26 Conversely, dominant vasodepressor forms hopefully can benefit from the withdrawal of hypotensive drug therapy, which is frequently prescribed for CSS patients because of associated comorbidities.
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Limitations
The above-mentioned effects of atropine on upright BP could be a confounding factor in the interpretation of the results of CSM. Temporary sequential pacing is a widely accepted method of preventing the confounding effects of asystole on the fall in arterial pressure induced by CSM. 25, 28 It is clear that temporary sequential atrioventricular pacing would add greatly to the complexity of what is otherwise regarded as a noninvasive, bedside, diagnostic procedure. In clinical practice, therefore, atropine administration is preferred to temporary dual-chamber pacing in quantifying the vasodepressor reflex, as it is simple, noninvasive, and easily reproducible. 11 Almquist et al 28 found similar vasodepressor effects in CSS patients on atrioventricular pacing and those on atropine.
The reproducibility of the effects of CSM was not tested in the patients enrolled in this study. The reproducibility of the Method of Symptoms had been previously tested by us. In a study, 29 in 42 patients with a maximum asystolic pause ranging from normal to extremely abnormal during the first CSM, a significant correlation (r=0.79) was found with a second massage performed 1 hour to 3 months later; moreover, concordance in normal or abnormal responses was found in 93% of cases. In another study, 11 in 54 patients affected by CSS with prolonged asystolic pauses of 7.7±2.1 s (range 3-13), CSM was repeated after 15 months and revealed an asystolic pause of 6.5±1.6 s (range 3-10); syncope was reproduced in 46 of the 49 (94%) patients and presyncope in 4 out of the other 5 (80%) patients. Admittedly, CSM is a highly operator-dependent test. In this study, the evaluation was performed by a small number of expert operators in accordance with a precise standardized protocol inside a structured organization. The results might have been different if the tests had been performed in different settings. Manual compression by different investigators can yield different results. Reproducibility has been questioned by others. 30 Previous studies have used a suction method, which, while not used clinically, may be more consistent. 31 
Conclusions
These observations may contribute to clarifying the physiology of the mechanism responsible for symptoms. By providing an objective measurement of the magnitude of the vasodepressor reflex, the standardized execution of CSM according to this protocol will help physicians to select the most appropriate therapy and will help researchers to design future studies.
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